Nurix Therapeutics, Inc. (NRIX) stock
NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3072% below fair value
$14.73−0.75 (-4.84%)
Close on Nov 16, 2026Market cap $1.61BP/E 6.4Yield 0.00%
Nurix Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Nurix Therapeutics's market cap was $1.78B on Nov 11, 2026, against $1.36B a year earlier. Over the last 5 years it ranged from $271.14M to $2.93B, with a median of $810.38M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.78B | +22.3% |
| 2025 | Dec 31, 2025 | $1.46B | +15.4% |
| 2024 | Dec 31, 2024 | $1.26B | +152.5% |
| 2023 | Dec 29, 2023 | $500.56M | -3.3% |
| 2022 | Dec 30, 2022 | $517.68M | -59.9% |
| 2021 | Dec 31, 2021 | $1.29B | +1.0% |
| 2020 | Dec 31, 2020 | $1.28B | – |
See a number that looks wrong?